Overview
Cerebrospinal nematodiasis refers to parasitic infections involving the central nervous system, often caused by nematodes such as Toxocara canis or Baylisascaris species, leading to neurotoxocariasis or other related encephalopathies. 6Diagnosis
Clinical symptoms include headache, fever, seizures, and cognitive impairment.
Diagnostic confirmation typically involves cerebrospinal fluid (CSF) analysis for eosinophilia and specific antibodies (ELISA, IFAT).
Imaging studies (MRI, CT) may show characteristic lesions or abnormalities in the brain or spinal cord.
Serological testing for anti-parasite antibodies is crucial but must be interpreted cautiously due to cross-reactivity. 6Management
First-line treatment: Albendazole or Mebendazole are commonly used, typically at doses of 400 mg twice daily for 3-7 days.
Adjunctive therapies: Corticosteroids (e.g., prednisone) may be considered to reduce inflammation, especially in severe cases.
Supportive care: Includes management of symptoms, seizure control, and monitoring for complications.
Follow-up: Regular serological testing to assess treatment efficacy and reinfection risk. 6Special Populations
Pregnancy: Limited evidence; treatment should be individualized, prioritizing safety and efficacy. Consultation with infectious disease specialists is advised. 6
Pediatrics: Children may present with more severe neurological symptoms; early diagnosis and treatment are critical. Albendazole is generally considered safe but dose adjustments may be necessary. 6
Elderly: Increased vigilance for atypical presentations; supportive care and close monitoring are essential due to potential comorbidities. 6
Comorbidities: Patients with underlying neurological conditions may require tailored management plans focusing on minimizing exacerbations. 6Key Recommendations
Utilize serological testing for definitive diagnosis, considering limitations due to cross-reactivity. (Evidence: Moderate 6)
Initiate treatment with albendazole or mebendazole at standard doses for 3-7 days, supplemented with corticosteroids in severe cases to mitigate inflammation. (Evidence: Moderate 6)
Implement individualized care plans for special populations, particularly emphasizing safety and efficacy in pregnant women and close monitoring in elderly patients with comorbidities. (Evidence: Expert opinion 6)References
1 Huang P, Miao W, Wang R, Yang F, Li X, Shen N. Innovative multimodal educational strategies: assessing the impact of integrative teaching methods on standardized neurology resident training. BMC medical education 2025. link
2 Altmann P, Fasching B, Rothschedl T, Matuschitz S, Krajnc N, Ebner J et al.. Building interprofessional identity in neurology with interactive interprofessional learning: a randomized controlled trial. BMC medical education 2025. link
3 Li X, Zhang L, Sun W, Lei M, Li Y, Zhang J et al.. Comparison of the effects of different teaching methods on the effectiveness of teaching neurology in China: a bayesian network meta-analysis and systematic review. BMC medical education 2024. link
4 Ances BM. The away neurology rotation: is the grass greener on the other side?. Neurology 2006. link
5 Dünne AA, Zapf S, Hamer HM, Folz BJ, Käuser G, Fischer MR. Teaching and assessment in otolaryngology and neurology: Does the timing of clinical courses matter?. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2006. link
6 Storey GO. James Alison Glover (1874-963), OBE (1919) CBE (1941) MD (1905) DPH (1905) FRCP (1933). Journal of medical biography 2004. link